Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Mondejar
Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pss25 - Cost-Effectiveness Analysis of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema (Dme) Under the Brazilian Public Healthcare System (Sus)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Ranibizumab Versus Aflibercept in the Treatment of Visual Impairment Due to Diabetic Macular Edema: A UK Healthcare Perspective
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Effect of Intravitreal Aflibercept on Recalcitrant Diabetic Macular Edema
International Journal of Retina and Vitreous
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results
Ophthalmology
Ophthalmology
Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Intravitreal Corticosteroids in the Management of Diabetic Macular Edema
Current Ophthalmology Reports
Ophthalmology
Systematic Review and Mixed Treatment Comparison of Intravitreal Aflibercept With Other Therapies for Diabetic Macular Edema (DME)
BMC Ophthalmology
Medicine
Ophthalmology
